Statement of need
The diagnostic parameters for the myeloid malignancies are complex. Many therapies are being used, and many more novel options are being tested for the various diseases. There is a need to bring issues surrounding diagnostic and treatment decisions to the forefront for physicians treating patients with these malignancies.
Goals and objectives
All North Shore-Long Island Jewish Health System CME activities are designed to lead to improved patient care and patient safety. At the conclusion of this activity, participants should be able to:
- Define symptoms, classification, and diagnostic differences among AML, MDS, and CML
- Discuss the pros and cons of the current standard treatment options for the myeloid malignancies
- Recognize unusual cases within the disease categories and assess the various treatment options for them
Target audience
Hematologists, oncologists, fellows in hematology/oncology, allied health professionals
CME accreditation
North Shore-Long Island Jewish (LIJ) Health System is accredited by the Accreditation Council for Continuing Medical Education to provide Continuing Medical Education for physicians.
The North Shore-Long Island Jewish Health System designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.
Hardware & Software Requirements
Supported Browsers
Internet Explorer v.6 or greater (for Windows)
Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)
Minimum System Requirements
Windows Systems Requirements
-
A Pentium-based PC or compatible computer.
-
At least 64MB of RAM.
-
Windows 95/98/NT/ME/2000/XP/Vista system software.
-
A Sound Blaster or compatible sound card and speakers.
-
DirectX version 3.0 or later recommended.
-
Screen resolution of 1024 x 786 or larger recommended.
-
-
Mac OS System Requirements
An educational grant from Cephalon Oncology made this activity possible.
|
